Company Update

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs for pre-clinical and clinical trials, announces the appointment of David Osband as EVP, Sales & Marketing. David joins Sword with a proven track record in the contract research space. Most notably, he was an owner of Cambridge Biomedical,…

Sword Bio (“Sword”), a contract research organization that supports biotech and pharmaceutical companies with their bioanalytical needs from development to clinical trials, announces the appointment of Matthew Langevin as Chief Operating Officer. Matt joins Sword with exceptional experience and a proven track record in the contract research space. Most notably, he was Co-Founder of BioAgilytix,…